drugset / Trial / NCT01992172

Photocil (Topical) for the Treatment of Atopic Dermatitis

NCT01992172 ↗

Completed 7 enrolled Applied Biology, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Photocil is a topical drug (cream) that selectively delivers Narrow Band - Ultraviolet B (NB-UVB) therapy when exposed to sunlight. Photocil is intended to help protect users from non-therapeutic Ultraviolet B (UVB) radiation while selectively passing wavelengths of light in the NB-UVB range with peak transmission of 308nm. The aim of the study is to assess the safety and efficacy of Photocil in the treatment of atopic dermatitis.

Timeline

Start
2013-08
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Photocil Unknown — Topical

Indications